Literature DB >> 4991920

Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli.

V Lorian, L D Sabath.   

Abstract

Erythromycin was found to be a more effective inhibitor of gram-negative bacilli in alkaline medium than in neutral or acid medium. A definite effect was noted with all of 500 recent clinical isolates of Escherichia coli, Klebsiella-Enterobacter, Pseudomonas aeruginosa, and Proteus mirabilis studied, but it was most striking with E. coli. At pH 8.5 all strains, except for 14% of those of P. mirabilis, were inhibited by concentrations of erythromycin readily achieved in urine with common therapeutic doses.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4991920      PMCID: PMC377039          DOI: 10.1128/am.20.5.754-756.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  6 in total

1.  Sensitivity of E. coli, Ps. aeruginosa and B. proteus to erythromycin in various pH culture media.

Authors:  Z ZAGAR
Journal:  Chemotherapia (Basel)       Date:  1963

2.  The susceptibility of coliform bacilli to erythromycin.

Authors:  G M WILLIAMSON; K ZINNEMANN
Journal:  Antibiot Chemother (Northfield)       Date:  1962-03

3.  Behaviour in vitro of some new antistaphylococcal antibiotics.

Authors:  L P GARROD; P M WATERWORTH
Journal:  Br Med J       Date:  1956-07-14

4.  Routine titrations of Lansing virus and antibody in mice: comparison of methods of estimating endpoints.

Authors:  D B W REID; E M CLARK; A J RHODES
Journal:  Proc Soc Exp Biol Med       Date:  1952-10

5.  Erythromycin plus alkalinization in treatment of urinary infections.

Authors:  S H Zinner; L D Abath; J I Casey; M Finland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

6.  Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.

Authors:  L D Sabath; V Lorian; D Gerstein; P B Loder; M Finland
Journal:  Appl Microbiol       Date:  1968-09
  6 in total
  23 in total

1.  Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents.

Authors:  M M Johnson; S L Hill; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 3.267

Review 3.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

4.  Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.

Authors:  C C Crowe; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

5.  Modified microdilution susceptibility test for staphylococci, streptococci and Haemophilus spp.

Authors:  R J Fass; V L Helsel
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

6.  Rapid microassays for clindamycin and gentamicin when present together and the effect of pH and of each on the antibacterial activity of the other.

Authors:  L D Sabath; I Toftegaard
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

7.  In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Authors:  K B Waites; L B Duffy; T Schmid; D Crabb; M S Pate; G H Cassell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 8.  Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.

Authors:  G H Cassell; K B Waites; H L Watson; D T Crouse; R Harasawa
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

9.  Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin.

Authors:  E J Goldstein; V L Sutter; Y Y Kwok; R P Lewis; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

10.  Comparative in vitro activity of clarithromycin. Spanish Collaborative Group.

Authors:  E Loza; J Martínez Beltrán; F Baquero; A León; R Cantón; B Garijo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.